OverviewSuggest Edit

DarioHealth develops medical device designed to test blood sugar levels via smartphones. Its testing device analyzes consumer health data to personalize treatment and advance medical knowledge, enabling diabetes management and monitoring system to native smart phone application, website portal and a wide variety of treatment tools to support more proactive and better informed decisions by users living with diabetes, their doctors and healthcare systems.

TypePublic
Founded2010
HQNew York, US
Websitemydario.com

Latest Updates

Employees (est.) (Dec 2019)62(-10%)
Revenue (FY, 2019)$7.6 M(+3%)
Share Price (Sept 2020)$17.4 (-5%)
Cybersecurity ratingCMore

DarioHealth Office Locations

DarioHealth has offices in New York, Burlington, Caesarea and Royal Leamington Spa
New York, US (HQ)
142 W 57th St 8th floor
Burlington, US
1500 District Ave #1089
Caesarea, IL
8 Ha-Tokhen St
Royal Leamington Spa, GB
Tachbrook Park, Athena Court, Athena Dr
Show all (4)

DarioHealth Financials and Metrics

DarioHealth Revenue

DarioHealth's revenue was reported to be $7.56 m in FY, 2019
USD

Revenue (Q2, 2020)

1.8m

Gross profit (Q2, 2020)

636.0k

Gross profit margin (Q2, 2020), %

35.6%

Net income (Q2, 2020)

(4.8m)

EBIT (Q2, 2020)

(4.1m)

Market capitalization (17-Sept-2020)

132.2m

Closing stock price (17-Sept-2020)

17.4

Cash (30-Jun-2020)

13.2m

EV

119.6m
DarioHealth's current market capitalization is $132.2 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

51.0k823.0k2.8m5.2m7.4m7.6m

Revenue growth, %

1514%241%

Cost of goods sold

2.3m1.7m3.4m3.9m5.6m5.0m

Gross profit

(2.2m)(855.0k)(561.0k)1.3m1.8m2.6m
Quarterly
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

2.3m1.5m2.7m1.1m3.7m11.0m20.4m

Accounts Receivable

99.3m282.0k168.0k672.0k

Prepaid Expenses

474.8k286.0k935.0k604.0k591.0k267.0k

Inventories

234.0k601.0k888.0k1.2m1.4m1.4m
USDQ1, 2013

Financial Leverage

-0.5 x
Show all financial metrics

DarioHealth Operating Metrics

FY, 2016

Patents (US)

2
Show all operating metrics

DarioHealth Cybersecurity Score

Cybersecurity ratingPremium dataset

C

73/100

SecurityScorecard logo

DarioHealth Online and Social Media Presence

Embed Graph

DarioHealth News and Updates

DarioHealth Announces Two Remote Patient Monitoring (RPM) Agreements and Commences Enrollment

NEW YORK, June 11, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company has signed its first two remote patient monitoring (RPM) agreements. Remote patient monitoring will allow treating physicians to...

DarioHealth Strengthens Management Team With Appointment of Digital Health Veteran Rick Anderson as President and General Manager, North America

NEW YORK, Jan. 9, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today the appointment of Richard Anderson as its President and General Manager of North America, effective January 13,...

Dance Biopharm Partners With DarioHealth to Expand Access to Digital Therapeutics Platform for Patients With Chronic Diseases

DURHAM, North Carolina and NEW YORK, Sept. 11, 2019 /PRNewswire/ -- Dance Biopharm Holdings, Inc., a clinical-stage company reimagining the treatment of chronic diseases with inhaled therapies, announced today it has formed a strategic alliance with DarioHealth Corp. "Dario" (Nasdaq:...

DarioHealth Announces Alliance with DigitalHealth.London As Part of the UK Israel Dangoor Health Initiative

NEW YORK and CAESAREA, Israel, Aug. 15, 2019 /PRNewswire/ -- DarioHealth Corp. ("DarioHealth" or "Dario") (Nasdaq: DRIO), a leading, global digital therapeutics company, today announced an alliance with DigitalHealth.London ("DH.L") as part of its UK Israel Dangoor Health Initiative (the...

DarioHealth Reports Results For Second Quarter 2019

NEW YORK and CAESAREA, Israel, Aug. 13, 2019 /PRNewswire/ -- Q2 2019 Revenue of $1.65 million, a 20% decline from Q2 2018 Record 1H 2019 Revenue of $3.89 million, a 2% increase over 1H 2018 Expense shift from D2C to B2B, resulting in a short-term decline in Revenue and an expectation of...

DarioHealth Granted 180-day Extension by Nasdaq to Regain Compliance With bid Price Rule

NEW YORK and CAESAREA, Israel, July 8, 2019 /PRNewswire/ -- Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced that on July 5, 2019, it received notification from Nasdaq that the Company has been granted an additional 180-day compliance period, or until ...
Show more

DarioHealth Blogs

Facts about healthy sleep

Facts about healthy sleep We spend up to one-third of our lives asleep. Sleep is necessary to maintain critical body … Read more

Dawn Phenomenon and Somogyi Effect

Dawn Phenomenon and Somogyi Effect Background: Morning blood glucose level taken first thing in the morning before eating or drinking … Read more

Articles archive

Get Motivated, Stay Motivated

Get Motivated, Stay Motivated Motivation to make significant lifestyle changes is a major factor in your success for managing your … Read more

Harmful effects about smoking you may not know about

Harmful effects about smoking you may not know about There is no doubt that tobacco is bad for your health. … Read more

Diabetes and cardiovascular disease – what is the link and why is it so important?

Diabetes and cardiovascular disease – what is the link and why is it so important? Diabetes and cardiovascular disease (CVD) … Read more
Show more

DarioHealth Frequently Asked Questions

  • When was DarioHealth founded?

    DarioHealth was founded in 2010.

  • How many employees does DarioHealth have?

    DarioHealth has 62 employees.

  • What is DarioHealth revenue?

    Latest DarioHealth annual revenue is $7.6 m.

  • What is DarioHealth revenue per employee?

    Latest DarioHealth revenue per employee is $121.9 k.

  • Who are DarioHealth competitors?

    Competitors of DarioHealth include Vim, SilverCloud Health and Gobiquity.

  • Where is DarioHealth headquarters?

    DarioHealth headquarters is located at 142 W 57th St 8th floor, New York.

  • Where are DarioHealth offices?

    DarioHealth has offices in New York, Burlington, Caesarea and Royal Leamington Spa.

  • How many offices does DarioHealth have?

    DarioHealth has 4 offices.